Providence Medical Technology was issued four additional U.S. patents relating to DTRAX® and CAVUX® posterior cervical spinal fixation technologies.
Oxford Finance closed a US $20MM senior secured term loan with Cerapedics. Proceeds will support commercialization of i-FACTOR bone graft for ACDF and fund an FDA study on its application in TLIF.
Six-year study results on the treatment of SI joint disorders indicated that treatment with conservative management or radiofrequency denervation led to worsened outcomes, while iFuse Implant patients demonstrated superior improvements.
Two-year clinical results from a study of BioPoly’s RS Partial Resurfacing Knee indicate statistically significant and clinically meaningful improvement in knee pain and function.